Landscapes / Companies
Checkpoint Therapeutics, Inc. not checked
FollowEvery new trial, moved date and filing, and a Monday email
Next date
None yet
Drugs
1
in active trials · 2 in all
Trials
1 active
3 since 2021
Drugs1
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
Programmed death ligand-1 blocker |
Approved | — | |||
| How it works | Releases a brake on the immune system (PD-1 or PD-L1) so it attacks cancer cells | ||||
| Also tested for | Lung Neoplasms, Carcinoma, Non-Small-Cell Lung and 11 more | ||||
| Open drug page | |||||
About
- No active trial
- CK-101
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 Industry-sponsored drug trials since 2021